Chuansha, Shanghai, June 29, 2020. — Convalife and Medicilon signed a strategic pact, initiating a long-term cooperation between the two companies. Based on previous cooperation and the mutual trust, Medicilon and Convalife achieved consensus on the partnership that Medicilon will assist Convalife in new drug development utilizing its integrated pharmaceutical R&D service platform. According toRead more
Blog
By medicilon | Medicilon Events | Comments are Closed | 30 June, 2020 |
By medicilon | Featured Stories | Comments are Closed | 26 May, 2020 |
On May 22, 2020, Kintor Pharmaceutical Limited (stock code: 9939. HK) was officially listed on the Hong Kong Stock Exchange. We medicilon extend the congratulations and best wishes. Medicilon has joined hands with in multiple pharmaceutical development projects in recent years, including external preclinical pharmacokinetic studies and safety evaluation of the androgen receptor antagonist FrestatinRead more